Probing the O-Glycoproteome of Gastric Cancer Cell Lines for Biomarker Discovery*

Autor: Sergey Y. Vakhrushev, Daniela Freitas, J. Sousa, Catharina Steentoft, Luís Pedro Afonso, Catarina Gomes, Diana Campos, Ana Magalhães, Celso A. Reis, Malene Bech Vester-Christensen, Ulla Mandel, Lúcio Lara Santos, Henrik Clausen, Joana Gomes, José Alexandre Ferreira
Přispěvatelé: Instituto de Investigação e Inovação em Saúde
Rok vydání: 2015
Předmět:
Male
N-Acetylgalactosaminyltransferases/blood
Proteome
Glycoproteins/metabolism
Proximity ligation assay
Biology
Stomach Neoplasms/metabolism
Biochemistry
Analytical Chemistry
03 medical and health sciences
0302 clinical medicine
Stomach Neoplasms
Cell Line
Tumor

Biomarkers
Tumor

medicine
N-Acetylgalactosaminyltransferases/metabolism
Humans
Biomarker discovery
Glycoproteins/blood
Molecular Biology
Aged
Glycoproteins
030304 developmental biology
Aged
80 and over

chemistry.chemical_classification
0303 health sciences
Research
CD44
Cancer
Middle Aged
medicine.disease
3. Good health
chemistry
Biomarkers
Tumor/blood

Biomarkers
Tumor/metabolism

030220 oncology & carcinogenesis
Cancer cell
Immunology
Cancer research
biology.protein
Stomach Neoplasms/blood
N-Acetylgalactosaminyltransferases
Biomarker (medicine)
Female
Glycoprotein
Zdroj: Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
ISSN: 1535-9476
DOI: 10.1074/mcp.m114.046862
Popis: Circulating O-glycoproteins shed from cancer cells represent important serum biomarkers for diagnostic and prognostic purposes. We have recently shown that selective detection of cancer-associated aberrant glycoforms of circulating O-glycoprotein biomarkers can increase specificity of cancer biomarker assays. However, the current knowledge of secreted and circulating O-glycoproteins is limited. Here, we used the COSMC KO "Simple- Cell" (SC) strategy to characterize the O-glycoproteome of two gastric cancer SimpleCell lines (AGS, MKN45) as well as a gastric cell line (KATO III) which naturally expresses at least partially truncated O-glycans. Overall, we identified 499 O-glycoproteins and 1236 O-glycosites in gastric cancer SimpleCells, and a total 47 O-glycoproteins and 73 O-glycosites in the KATO III cell line. We next modified the glycoproteomic strategy to apply it to pools of sera from gastric cancer and healthy individuals to identify circulating O-glycoproteins with the STn glycoform. We identified 37 O-glycoproteins in the pool of cancer sera, and only nine of these were also found in sera from healthy individuals. Two identified candidate O-glycoprotein biomarkers (CD44 and GalNAc-T5) circulating with the STn glycoform were further validated as being expressed in gastric cancer tissue. A proximity ligation assay was used to show that CD44 was expressed with the STn glycoform in gastric cancer tissues. The study provides a discovery strategy for aberrantly glycosylated O-glycoproteins and a set of O-glycoprotein candidates with biomarker potential in gastric cancer. This work was supported by The Danish Research Councils, The Mizutani Foundation, The Danish National Research Foundation (DNRF107) and Fundacão para a Ciência e a Tecnologia (FCT) and COMPETE (Programa Operacional Temático Factores de Competitividade, comparticipado pelo fundo comunitário europeu FEDER) in the framework of the projects: PTDC/BBB-EBI/0786/2012; EXPL/CTM-BIO/0762/2013. Grants were received from FCT (SFRH/BD/73717/2010 to DC), (SFRH/BPD/75871/2011 to AM), (SFRH/BPD/96510/2013 to CG) and (SFRH/BPD/66288/2009 to JAF). IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education, and is partially supported by FCT.
Databáze: OpenAIRE